US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 28.160
  • +0.210+0.75%
Trading Oct 17 09:43 ET
3.43BMarket Cap-10352P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q2
Stock NameRevenueRatio
SYFOVRE154.62M77.43%
EMPAVELI24.51M12.28%
Licensing and other revenue20.55M10.29%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States396.59M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Gene Editing
Gene Editing
Intraday+0.84%